Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 108

Sort by

Sort Order Select

Journal Articles

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

Megan C. Brown, MD, Michael H. White, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 627.

https://doi.org/10.1182/blood-2019-127258

Published: 2019

Journal Articles

Fitusiran, an RNAi Therapeutic Targeting Antithrombin to Restore Hemostatic Balance in Patients with Hemophilia a or B with or without Inhibitors: Management of Acute Bleeding Events

Steven Pipe, MD, Margaret V. Ragni, MD MPH, Claude Négrier, MD PhD, Qifeng Yu, PhD, Naghmana Bajwa, MD, John Caminis, MD, Baisong Mei, MD PhD, Shauna R. Andersson, MD PhD

Blood (2019) 134 (Supplement_1): 1138.

https://doi.org/10.1182/blood-2019-124108

Published: 2019

Journal Articles

Evaluation of the in Vitro Procoagulant Effect of Factor IX Concentrates in Patients on Prophylaxis with Emicizumab

Ihosvany Fernandez-Bello, María Teresa Alvarez Román, Mónica Martín, María Isabel Rivas Pollmar, Sara García Barcenilla, Carmen García Martínez, Tamara Cebanu, Paula Acuña, Raul Justo Sanz, Elena Monzón Manzano, Miguel A Canales, MD PhD, Nora Butta, PhD, Victor Jimenez-Yuste

Blood (2019) 134 (Supplement_1): 1118.

https://doi.org/10.1182/blood-2019-129983

Published: 2019

Journal Articles

Fast Onset of Action of Subcutaneously Administered Marzeptacog Alfa (Activated) Supports on-Demand Treatment in Hemophilia a Mice

Frank Del Greco, MBA, Linda Neuman, MD, Howard Levy, PhD MBBChir, Jill Reckless, Tom Knudsen, PhD DVM, Grant E. Blouse, PhD

Blood (2019) 134 (Supplement_1): 2420.

https://doi.org/10.1182/blood-2019-128971

Published: 2019

Journal Articles

Quantitative Measurements of Hemophilic Joint Tissues By Point-of-Care Musculoskeletal Ultrasound Are Associated with Clinical and Functional Joint Outcome Parameters

Akram Mesleh Shayeb, MD, Richard Barnes, PhD MPH, Cris Hanacek, BS, Andres Flores, MS, ATC, CES, Rebecca Kruse-Jarres, MDMPH, Bruno Steiner, PT, DPT, LMT, RMSK, Doris Quon, MD PhD, Cindy Bailey, DPT, OCS, SCS, ATC, Annette von Drygalski, MD PharmD

Blood (2019) 134 (Supplement_1): 905.

https://doi.org/10.1182/blood-2019-129690

Published: 2019

Journal Articles

Education Program to Improve the Adherence to Guidelines for Use of Blood Transfusions in Sickle Cell Disease

Jennel Zeppieri, MD BSc, Dongyoun Deborah Park, MD BA, Kelley Mowatt, DO, Mohammed Sharif, MD, Alice J. Cohen, MD

Blood (2019) 134 (Supplement_1): 2115.

https://doi.org/10.1182/blood-2019-131766

Published: 2019

Journal Articles

Macrophage Hypercellularity Accompanies Erythroid Hyperplasia in Sickle Cell Mice and during Recovery from Blood Loss in Wild Type Mice

Oluwabukola Gbotosho, BSc, MSc, PhD, Maria G Kapetanaki, PhD, Samit Ghosh, Frances Weidert, MS, Grant C. Bullock, MD PhD, Solomon Fiifi Ofori-Acquah, Gregory J Kato, MD

Blood (2019) 134 (Supplement_1): 3528.

https://doi.org/10.1182/blood-2019-127224

Published: 2019

Journal Articles

Characterization of a Novel Human Factor VIIa Chimera with Increased Tissue Factor-Independent Activity for Emergency Hemostasis

Ammon Fager, MD PhD, Maureane Hoffman, MD PhD, Dougald Monroe, PhD

Blood (2019) 134 (Supplement_1): 3623.

https://doi.org/10.1182/blood-2019-124428

Published: 2019

Journal Articles

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Paulette Bryant, MD, Jenny McDaniel, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 1126.

https://doi.org/10.1182/blood-2019-126659

Published: 2019

Journal Articles

Nrf2 Null Mice Are Deficient in CD169 + Macrophages, Associated with Impaired Erythroid Response and Delayed Recovery from Acute Blood Loss

Oluwabukola Gbotosho, BSc, MSc, PhD, Maria G Kapetanaki, PhD, Mark A Ross, Samit Ghosh, Frances Weidert, MS, Grant C. Bullock, MD PhD, Solomon Fiifi Ofori-Acquah, Gregory J Kato, MD, Simon Watkins

Blood (2019) 134 (Supplement_1): 1038.

https://doi.org/10.1182/blood-2019-127295

Published: 2019

Journal Articles

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Mark T. Reding, MD, Jatin Rana, MD, Michael U. Callaghan, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD

Blood (2018) 132 (Supplement 1): 635.

https://doi.org/10.1182/blood-2018-99-115089

Published: 2018

Journal Articles

Macrophage Polarization Is Impaired in Hemophilia

Lynn M Knowles, PhD, Daniela Lessig, Martin Bernard, Eva C Schwarz, PhD, Hermann Eichler, MD, Jan Pilch, MD

Blood (2018) 132 (Supplement 1): 2499.

https://doi.org/10.1182/blood-2018-99-117111

Published: 2018

Journal Articles

Efficacy and Pharmacokinetics of a New Fibrinogen Concentrate in Treating Acute Bleeding in Adolescent Patients with Congenital Fibrinogen Deficiency

Flora Peyvandi, MD PhD, Bruce A. Schwartz, Sigurd Knaub

Blood (2018) 132 (Supplement 1): 2501.

https://doi.org/10.1182/blood-2018-99-116572

Published: 2018

Journal Articles

Efficacy and Safety of Fibrinogen Concentrate for on-Demand Treatment of Acute Bleeding and for Surgical Prophylaxis in Subjects with Congenital Fibrinogen Deficiency — a Phase 3 Study

Flora Peyvandi, MD PhD, Bruce A. Schwartz, Sigurd Knaub

Blood (2018) 132 (Supplement 1): 2502.

https://doi.org/10.1182/blood-2018-99-116440

Published: 2018

Journal Articles

Final Results from a Non-Interventional Safety and Efficacy Study of a VWF/FVIII Concentrate (wilate ® ) in Patients with Von Willebrand Disease

Hassan M. Yaish, MD, Maria Sol Cruz, MD, Kay Decker, Eva M.K. Zetterberg, MD PhD, Sylvia Werner, Mariko Hashimoto, Sigurd Knaub, George M. Rodgers, MD PhD

Blood (2018) 132 (Supplement 1): 1182.

https://doi.org/10.1182/blood-2018-99-118069

Published: 2018

Journal Articles

Thrombocytosis in Iron Deficiency Anemia

Hemendra Mhadgut, MD, Hadiza Galadima, PhD, Hassan Raymond Tahhan, MD

Blood (2018) 132 (Supplement 1): 4985.

https://doi.org/10.1182/blood-2018-99-119352

Published: 2018

Journal Articles

NCOA4 Mediates Mobilization of Hepatic Iron Stores after Blood Loss

Xiuqi Li, MS, Larisa Lozovatsky, MS, Dong Liu, PhD, Nadia Ayala-Lopez, PhD MT(ASCP), Karin E. Finberg, MD PhD

Blood (2018) 132 (Supplement 1): 1046.

https://doi.org/10.1182/blood-2018-99-119469

Published: 2018

Journal Articles

Safe and Effective Implementation of a Red Blood Cell (RBC) Transfusion Hemoglobin (Hb) Threshold of 7 g/Dl on an Inpatient Stem Cell Transplant Unit: A Single Institution Experience

Melissa M. Cushing, MD, Ljiljana Vasovic, MD, Kathleen Kane, Usama Gergis, MD, Adriana C. Rossi, MDMSc, Adrienne A. Phillips, MD MPH, Yen-Michael S. Hsu, MD PhD, Craig Budzinski, Sebastian A. Mayer, MD, Jingmei Hsu, MD PhD, Sangmin Lee, MD, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD, Ruchika Goel, MD MPH

Blood (2017) 130 (Supplement 1): 1131.

https://doi.org/10.1182/blood.V130.Suppl_1.1131.1131

Published: 2017

Journal Articles

Ethical Decision Making Framework in Previously Untreated Severe Hemophilia A Patients

Ashley Foster Lanzel, MD, J. Michael Soucie, PhD, Shannon L. Meeks, MD, Robert F. Sidonio, Leonard Ortmann, PhD, Drue H Barrett, PhD

Blood (2017) 130 (Supplement 1): 5583.

https://doi.org/10.1182/blood.V130.Suppl_1.5583.5583

Published: 2017

Journal Articles

Sickle Cell Disease and the Adherence to Guidelines for Use of Blood Transfusions

Dongyoun Deborah Park, MD BA, Diana Grace Jacob, MD, Adeboye Adedemola, MD, Kelley Mowatt, DO, Tilisha Persaud, Asha Tipirneni, Carol Carson, Alice J. Cohen, MD

Blood (2017) 130 (Supplement 1): 4652.

https://doi.org/10.1182/blood.V130.Suppl_1.4652.4652

Published: 2017

NARROW

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

Fitusiran, an RNAi Therapeutic Targeting Antithrombin to Restore Hemostatic Balance in Patients with Hemophilia a or B with or without Inhibitors: Management of Acute Bleeding Events

Evaluation of the in Vitro Procoagulant Effect of Factor IX Concentrates in Patients on Prophylaxis with Emicizumab

Fast Onset of Action of Subcutaneously Administered Marzeptacog Alfa (Activated) Supports on-Demand Treatment in Hemophilia a Mice

Quantitative Measurements of Hemophilic Joint Tissues By Point-of-Care Musculoskeletal Ultrasound Are Associated with Clinical and Functional Joint Outcome Parameters

Education Program to Improve the Adherence to Guidelines for Use of Blood Transfusions in Sickle Cell Disease

Macrophage Hypercellularity Accompanies Erythroid Hyperplasia in Sickle Cell Mice and during Recovery from Blood Loss in Wild Type Mice

Characterization of a Novel Human Factor VIIa Chimera with Increased Tissue Factor-Independent Activity for Emergency Hemostasis

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Nrf2 Null Mice Are Deficient in CD169 + Macrophages, Associated with Impaired Erythroid Response and Delayed Recovery from Acute Blood Loss

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Macrophage Polarization Is Impaired in Hemophilia

Efficacy and Pharmacokinetics of a New Fibrinogen Concentrate in Treating Acute Bleeding in Adolescent Patients with Congenital Fibrinogen Deficiency

Efficacy and Safety of Fibrinogen Concentrate for on-Demand Treatment of Acute Bleeding and for Surgical Prophylaxis in Subjects with Congenital Fibrinogen Deficiency — a Phase 3 Study

Final Results from a Non-Interventional Safety and Efficacy Study of a VWF/FVIII Concentrate (wilate ® ) in Patients with Von Willebrand Disease

Thrombocytosis in Iron Deficiency Anemia

NCOA4 Mediates Mobilization of Hepatic Iron Stores after Blood Loss

Safe and Effective Implementation of a Red Blood Cell (RBC) Transfusion Hemoglobin (Hb) Threshold of 7 g/Dl on an Inpatient Stem Cell Transplant Unit: A Single Institution Experience

Ethical Decision Making Framework in Previously Untreated Severe Hemophilia A Patients

Sickle Cell Disease and the Adherence to Guidelines for Use of Blood Transfusions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only